REMS for Isotretinoin: iPLEDGE Requirements and Safety in 2025
iPLEDGE is the FDA's strict program to prevent birth defects from isotretinoin. Learn the 2025 requirements, recent changes, and how to navigate the system without delays.
Tag: isotretinoin